CY1016A - Benzoxazole derivatives - Google Patents

Benzoxazole derivatives

Info

Publication number
CY1016A
CY1016A CY1016A CY101673A CY1016A CY 1016 A CY1016 A CY 1016A CY 1016 A CY1016 A CY 1016A CY 101673 A CY101673 A CY 101673A CY 1016 A CY1016 A CY 1016A
Authority
CY
Cyprus
Prior art keywords
benzoxazole derivatives
benzoxazole
derivatives
Prior art date
Application number
CY1016A
Other languages
English (en)
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of CY1016A publication Critical patent/CY1016A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
CY1016A 1972-05-18 1973-05-15 Benzoxazole derivatives CY1016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2340972A GB1435721A (en) 1972-05-18 1972-05-18 Benzoxazole derivatives

Publications (1)

Publication Number Publication Date
CY1016A true CY1016A (en) 1979-11-23

Family

ID=10195157

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1016A CY1016A (en) 1972-05-18 1973-05-15 Benzoxazole derivatives

Country Status (31)

Country Link
US (1) US3912748A (sh)
JP (6) JPS5912672B2 (sh)
KR (1) KR780000234B1 (sh)
AR (4) AR230991A1 (sh)
AT (1) AT333752B (sh)
BE (1) BE799790A (sh)
BG (1) BG21408A3 (sh)
CA (1) CA1029019A (sh)
CH (5) CH592071A5 (sh)
CS (1) CS200455B2 (sh)
CY (1) CY1016A (sh)
DD (1) DD105229A5 (sh)
DE (1) DE2324443A1 (sh)
DK (1) DK140340B (sh)
ES (1) ES414863A1 (sh)
FR (2) FR2184966B1 (sh)
GB (1) GB1435721A (sh)
HK (1) HK72579A (sh)
HU (1) HU167933B (sh)
IE (2) IE37564B1 (sh)
IL (2) IL42102A (sh)
KE (1) KE2975A (sh)
MY (1) MY8000063A (sh)
NL (1) NL170145C (sh)
PH (3) PH9685A (sh)
PL (3) PL94208B1 (sh)
RO (2) RO66800A (sh)
SE (3) SE386174B (sh)
SU (3) SU574157A3 (sh)
YU (3) YU130473A (sh)
ZA (1) ZA732791B (sh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888864A (en) 1973-06-29 1975-06-10 Hoffmann La Roche Amino lower alkyl ether derivatives of opium alkaloids
GB1495488A (en) * 1976-06-23 1977-12-21 Ippco Int Pharma Patents Co Es Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen
IT1099589B (it) * 1978-08-04 1985-09-18 Ravizza Spa Processo per la preparazione di derivati dell'acido benzoxazolil propionico
CA1125768A (en) * 1978-10-31 1982-06-15 Hoffmann-La Roche Limited Benzoxazole derivatives
GB2058381B (en) 1979-07-18 1983-01-19 Fuji Photo Film Co Ltd Colour photographic light-sensitive material containing dye-releasing redox compound
GR75153B (sh) * 1981-03-27 1984-07-13 Lilly Co Eli
IT1157295B (it) * 1982-07-19 1987-02-11 Ravizza Spa Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico
DE3413875A1 (de) * 1984-04-12 1985-10-17 Ludwig Heumann & Co GmbH, 8500 Nürnberg Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
US4873259A (en) * 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4822809A (en) * 1987-11-13 1989-04-18 Abbott Laboratories Benzazole lipoxygenase inhibiting compounds
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
WO2004046122A2 (en) * 2002-11-16 2004-06-03 Oxford Glycosciences (Uk) Ltd Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
WO2004076386A2 (en) 2003-02-25 2004-09-10 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
BRPI0519326A2 (pt) * 2004-12-15 2009-01-13 Dompe Pha R Ma Spa Res & Mfg derivados de Ácido 2-arilpropiânico e composiÇÕes farmacÊuticas contendo-os
RU2419610C2 (ru) 2005-05-26 2011-05-27 Ньюрон Системз, Инк. Композиции и способы лечения заболевания сетчатки
JP5369854B2 (ja) 2008-04-21 2013-12-18 住友化学株式会社 有害節足動物防除組成物および縮合複素環化合物
JP5885670B2 (ja) 2009-12-11 2016-03-15 アルデイラ セラピューティクス， インコーポレイテッド 黄斑変性の処置のための組成物および方法
KR102435676B1 (ko) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
EP2948436A4 (en) 2013-01-25 2016-07-13 Aldeyra Therapeutics Inc NOVEL CASES IN THE TREATMENT OF MACULAR GENERATION
WO2016021706A1 (ja) * 2014-08-08 2016-02-11 カズマパートナーズ株式会社 縮合複素環化合物
CN118724806A (zh) 2015-08-21 2024-10-01 奥尔德拉医疗公司 氘化化合物和其用途
AU2017264697A1 (en) 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
WO2018170476A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US11040039B2 (en) 2017-10-10 2021-06-22 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
JP2021533154A (ja) 2018-08-06 2021-12-02 アルデイラ セラピューティクス， インコーポレイテッド 多形化合物およびその使用
CN113056353B (zh) 2018-09-25 2022-11-01 奥尔德拉医疗公司 用于治疗干眼病的调配物
WO2020198064A1 (en) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
WO2021231792A1 (en) 2020-05-13 2021-11-18 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70860A (sh) *
NL285932A (sh) * 1961-11-27
CH516339A (de) * 1969-03-03 1971-12-15 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
IL37633A (en) * 1970-09-10 1975-08-31 Merck & Co Inc 2-(4-(2-benzoxazolyl)phenyl)alkanoic acid derivatives
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
GB1491863A (en) * 1973-10-23 1977-11-16 Lilly Industries Ltd 2,5-or 2,6-disubstituted benzoxazoles
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen

Also Published As

Publication number Publication date
JPS56167673A (en) 1981-12-23
PL89247B1 (sh) 1976-11-30
AR207857A1 (es) 1976-11-08
PH11718A (en) 1978-05-30
CS200455B2 (en) 1980-09-15
HU167933B (sh) 1976-01-28
IE37563B1 (en) 1977-08-17
YU117179A (en) 1981-08-31
CH594643A5 (sh) 1978-01-13
CH587834A5 (sh) 1977-05-13
DK140340B (da) 1979-08-06
SU580837A3 (ru) 1977-11-15
JPS4954363A (sh) 1974-05-27
ATA432573A (de) 1976-04-15
ZA732791B (en) 1974-12-24
SE435838B (sv) 1984-10-22
SE7509387L (sv) 1975-08-22
BE799790A (fr) 1973-11-19
SE434399B (sv) 1984-07-23
JPS5912672B2 (ja) 1984-03-24
JPS5929185B2 (ja) 1984-07-18
NL170145B (nl) 1982-05-03
FR2284592B1 (sh) 1979-01-05
CH595361A5 (sh) 1978-02-15
KE2975A (en) 1979-07-20
JPS56167675A (en) 1981-12-23
CH595362A5 (sh) 1978-02-15
US3912748A (en) 1975-10-14
AR212010A1 (es) 1978-04-28
NL7307018A (sh) 1973-11-20
MY8000063A (en) 1980-12-31
JPS59161346A (ja) 1984-09-12
SU582762A3 (ru) 1977-11-30
PH9685A (en) 1976-02-10
IE37564L (en) 1973-11-18
SE7710602L (sv) 1977-09-21
JPS56167674A (en) 1981-12-23
PL92565B1 (sh) 1977-04-30
AU5590773A (en) 1974-11-21
BG21408A3 (bg) 1976-05-20
IE37564B1 (en) 1977-08-17
YU130473A (en) 1981-08-31
SE386174B (sv) 1976-08-02
PL94208B1 (sh) 1977-07-30
CA1029019A (en) 1978-04-04
DD105229A5 (sh) 1974-04-12
JPS6021976B2 (ja) 1985-05-30
IL48711A0 (en) 1976-02-29
RO66800A (ro) 1982-03-24
GB1435721A (en) 1976-05-12
AT333752B (de) 1976-12-10
PH10704A (en) 1977-08-24
ES414863A1 (es) 1976-02-01
DE2324443A1 (de) 1973-11-29
DK140340C (sh) 1979-12-31
SU574157A3 (ru) 1977-09-25
YU36298B (en) 1982-06-18
IL42102A (en) 1977-07-31
HK72579A (en) 1979-10-19
JPS56167645A (en) 1981-12-23
FR2284592A1 (fr) 1976-04-09
KR780000234B1 (en) 1978-07-01
CH592071A5 (sh) 1977-10-14
RO66278A (ro) 1981-06-26
AR230991A1 (es) 1984-08-31
AR205021A1 (es) 1976-03-31
FR2184966B1 (sh) 1979-01-12
NL170145C (nl) 1982-10-01
YU117079A (en) 1981-08-31
FR2184966A1 (sh) 1973-12-28
IL42102A0 (en) 1973-06-29
IE37563L (en) 1973-11-18

Similar Documents

Publication Publication Date Title
ZA732791B (en) Benzoxazole derivatives
IL43795A (en) 3-aminoalkylamino-1-phenoxy-2-propanol derivatives
ZA741280B (en) Thiazole derivatives
CY963A (en) Dopamine derivatives
ZA728544B (en) Alpha-aryl-4-substituted piperidinoalkanol derivatives
ZA736059B (en) New quinoxaline-di-n-oxide derivatives
HK11279A (en) Benzocycloheptathiophene derivatives
GB1402219A (en) Berbine derivatives
ZA728917B (en) Oxaziniondole-and thiaziniondole derivatives
IL42943A (en) 16-methyl-prednisolone derivatives
IL41789A0 (en) Diphenylalkyllactamimide derivatives
IL43280A0 (en) Amidinourea derivatives
PH10465A (en) Debenzazecine derivatives
GB1405227A (en) Pheynlthioethyl-imidazole derivatives
ZA732129B (en) New phenylformamidine derivatives
ZA728875B (en) Pyrano-and thiopyranoindole derivatives
ZA734945B (en) New beta-aminoketone derivatives
ZA732677B (en) Thiazole derivative
AU5423773A (en) Alpha-pyrone derivatives
HK380A (en) Benzoisoindoline derivatives
PH10653A (en) Indolylimidoylquinoline derivatives
PH10601A (en) Diaza-oxa-bicyclodecane derivatives
AU5872373A (en) Isoxolidine derivatives
AU5916873A (en) Cyclohexanepentol derivative
GB1404382A (en) Homopyrimidazole derivatives